Little Known Facts About ABBV-744 as a potential therapeutic option for aggressive cancers.
Participant eaten grapefruit or grapefruit merchandise within 3 days prior to the very first dose of study drug.88 These preclinical studies deliver paradigms for long run clinical trials in AML, and using novel combinations of drugs is currently currently being investigated in clinical trials.In Segment C, individuals will get ABBV-744 and oral na